Skip to main content

Peer Review reports

From: Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

Original Submission
23 Aug 2017 Submitted Original manuscript
7 Nov 2017 Author responded Author comments - HUIGUO DING
Resubmission - Version 2
7 Nov 2017 Submitted Manuscript version 2
13 Jun 2018 Author responded Author comments - HUIGUO DING
10 May 2018 Reviewed Reviewer Report - Evangelos Cholongitas
15 May 2018 Reviewed Reviewer Report - Nobuyuki Toshikuni
8 Mar 2018 Reviewed Reviewer Report - Yoshihiko Yano
Resubmission - Version 3
13 Jun 2018 Submitted Manuscript version 3
26 Jul 2018 Author responded Author comments - Shuzhen Wang
7 Jul 2018 Reviewed Reviewer Report - Evangelos Cholongitas
24 Jun 2018 Reviewed Reviewer Report - Nobuyuki Toshikuni
Resubmission - Version 4
26 Jul 2018 Submitted Manuscript version 4
Publishing
3 Aug 2018 Editorially accepted
4 Sep 2018 Article published 10.1186/s12876-018-0857-0

You can find further information about peer review here.

Back to article page